drugset / Trial / NCT06555601
A First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB3101 in Healthy Participants
RandomizedSequentialTriple-blindBasic science
Summary
The purpose of the study is to evaluate the safety and tolerability of a single ascending dose of UCB3101 in cohorts of healthy male and female study participants.
Timeline
- Start
- 2024-07-31
- Primary completion
- 2025-11-24
- Completion
- 2025-11-24
Outcome
Outcome not reported
Stopped (Business): “sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UCB3101 | Unknown | — | — |
Indications
No indication recorded.